Find product and prescribing information, as well as other essential resources for Genentech’s oncology portfolio.

Product information and support

Downloadable healthcare provider resources for our oncology products.

Alecensa^® (alectinib)

Prescribing information

Important patient information

Safety Data Sheets:

ALECENSA^® Capsules (150 mg)

Avastin^® (bevacizumab)

Prescribing information

Healthcare provider letters

Safety Data Sheets:

AVASTIN^® Vials (100 mg)

AVASTIN^® Vials (400 mg)

Cotellic^® (cobimetinib)

Prescribing information

Important patient information

Safety Data Sheets:

COTELLIC Tablets (20 mg)

Erivedge^® (vismodegib)

Prescribing information

Healthcare provider letters

Medication guide

Safety Data Sheets:

ERIVEDGE^® Capsules (150 mg)

Gavreto^® (pralsetinib)

Prescribing information

Important patient information

Safety Data Sheets:

GAVRETO^® Capsules 100 mg

Gazyva^® (obinutuzumab)

Prescribing information

Healthcare provider letters

Safety Data Sheets:

GAZYVA^® Vials (1000 mg/40 ml)

Herceptin^® (trastuzumab)

Prescribing information

Healthcare provider letters

Safety Data Sheets:

HERCEPTIN^® Vials (440 mg)

HERCEPTIN^® Vials (150 mg)

Herceptin Hylecta^™ (trastuzumab and hyaluronidase-oysk)

Prescribing information

Safety Data Sheets:

HERCEPTIN HYLECTA^™ Vials (600 mg/5 ml)

Kadcyla^® (ado-trastuzumab emtansine)

Prescribing information

Healthcare provider letters

Safety Data Sheets:

KADCYLA^® Lyophilized Powder in Vials (100 mg)

KADCYLA^® Solution

KADCYLA^® Lyophilized Powder in Vials (160 mg)

Perjeta^® (pertuzumab)

Prescribing information

Safety Data Sheets:

PERJETA^® (420 mg)

Phesgo^™ (pertuzumab, trastuzumab, and hyaluronidase-zzxf)

Prescribing information

Safety Data Sheets:

PHESGO^™ (pertuzumab, trastuzumab & hyaluronidase-zzxf) Injection (60 mg/ml, 60 mg/ml)

PHESGO^™ (pertuzumab, trastuzumab & hyaluronidase-zzxf) Injection (80 mg/ml, 40 mg/ml)

Polivy^® (polatuzumab vedotin-piiq)

Prescribing information

Safety Data Sheets:

POLIVY^® Lyophilized Powder in Vials (140 mg)

Rituxan^® (rituximab)

Prescribing information

Healthcare provider letters

Medication guide

Safety Data Sheets:

RITUXAN^® Vials (100 mg/10 ml)

RITUXAN^® Vials (500 mg/50 ml)

Rituxan Hycela^® (rituximab and hyaluronidase human)

Prescribing information

Medication guide

Safety Data Sheets:

RITUXAN HYCELA^® Vials (1600 mg)

RITUXAN HYCELA^® Vials (1400 mg)

Rozlytrek^® (entrectinib)

Prescribing information

Important patient information

Safety Data Sheets:

ROZLYTREK^® Capsules (100 mg)

ROZLYTREK^® Capsules (200 mg)

Tarceva^® (erlotinib)

Prescribing information

Healthcare provider letters

Safety Data Sheets:

TARCEVA^® Tablets (25 mg)

TARCEVA^® Tablets (100 mg)

TARCEVA^® Tablets (150 mg)

Tecentriq^® (atezolizumab)

Prescribing information

Healthcare provider letters

Medication guide

Safety Data Sheets:

TECENTRIQ^® Vials (840 mg/14 ml)

TECENTRIQ^® Vials (1200 mg/20 ml)

Venclexta^® (venetoclax)

Prescribing information

Medication guide

Safety Data Sheets:

VENCLEXTA^® Tablets (10, 50, and 100 mg)

Xeloda^® (capecitabine)

Prescribing information

Important patient information

Safety Data Sheets:

XELODA^® Tablets (150 mg)

XELODA^® Tablets (500 mg)

Zelboraf^® (vemurafenib)

Prescribing information

Healthcare provider letters

Medication guide

Safety Data Sheets:

ZELBORAF^® F.C. Tablets (240 mg)

Scientific congress posters and presentations

Genentech facilitates scientific exchange with healthcare professionals and researchers at in-person and virtual congresses worldwide. Review oncology presentations at Medically, our international medical congress platform.

ALECENSA^®

AVASTIN^®

COTELLIC^®

ERIVEDGE^®

GAVRETO^®

GAZYVA^®

HERCEPTIN^®

KADCYLA^®

PERJETA^®

PHESGO^™

POLIVY^®

RITUXAN^®

ROZLYTREK^®

TARCEVA^®

TECENTRIQ^®

VENCLEXTA^®

XELODA^®

ZELBORAF^®

Oncology clinical trials

Use the links below to review active Genentech clinical trials in oncology.

Alecensa^® Trials at ClinicalTrials.gov

Avastin^® Trials at ClinicalTrials.gov

Cotellic^® Trials at ClinicalTrials.gov

Erivedge^® Trials at ClinicalTrials.gov

Gavreto^® Trials at ClinicalTrials.gov

Gazyva^® Trials at ClinicalTrials.gov

Herceptin^® Trials at ClinicalTrials.gov

Kadcyla^® Trials at ClinicalTrials.gov

Perjeta^® Trials at ClinicalTrials.gov

Phesgo™ Trials at ClinicalTrials.gov

Polivy^® Trials at ClinicalTrials.gov

Rituxan^® Trials at ClinicalTrials.gov

Rozlytrek^® Trials at ClinicalTrials.gov

Tarceva^® Trials at ClinicalTrials.gov

Tecentriq^® Trials at ClinicalTrials.gov

Venclexta^® Trials at ClinicalTrials.gov

Xeloda^® Trials at ClinicalTrials.gov

Zelboraf^® Trials at ClinicalTrials.gov